Inspire Medical price target raised to $198 from $187 at Wells Fargo

Wells Fargo raised the firm’s price target on Inspire Medical (INSP) to $198 from $187 and keeps an Equal Weight rating on the shares. The firm notes Inspire reported Q3 sales/EPS ahead of Street expectations and raised 2024 sales/EPS guidance. Q4 sales outlook is slightly softer due to hurricane/IV shortage headwinds, Wells adds.